Shiley-Marcos Alzheimer's Disease Research Center

What's New This Month

ADRC News:

Dr. Paul Aisen from the Alzheimer's Disease Cooperative Study Group at UC San Diego was featured in the Union Tribune on Sunday March 1st. To read the article, "The Alzheimer's Puzzle" click here.

The Shiley-Marcos Alzheiemer's Disease Research Center Celebrates its 30th Birthday!

For 30 years, UC San Diego Shiley-Marcos Alzheimer’s Disease Research Center
(ADRC) has been at the leading edge of research into the causes, characteristics and means to
effectively treat, and ultimately prevent, Alzheimer’s. Indeed, as one of the nation’s first five
ADRCs, the Shiley-Marcos ADRC was an innovator from the start, putting
UC San Diego and the broader region on the map as a center of excellence and promise in the fight
against Alzheimer’s.

As we mark three decades of Research, Caring and Collaboration, we acknowledge the outstanding
support of our friends, collaborators and study participants.

This is a story of community,
a moment of celebration and a journey of hope.

Please click here to show your support.

Click here to read the UT article, "Marking an Alzheimer's research milestone"

Darlene Shiley blows out the candles on a celebratory cake.

Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4)Trial

Still Enrolling!

If you do not have memory changes that exceed normal age-related changes and are interested in participating in a clinical drug trial designed to prevent Alzheimer's dementia, please click on this link to see if the A4 trial is a fit for you. If so, contact Chritsina Gigliotti, PhD for more information.

Alzheimer's in the News:

In case you missed the Alzheimer’s Disease Research Summit 2015: Path to Treatment and Prevention on February 9-10, 2015, the National Institutes of Health has posted video of the Summit online. You can view all or parts of the Summit at any time and for free.

Video of Summit Day 1 includes plenary lectures on the socioeconomic burden of Alzheimer’s in the U.S. and globally and what we now understand about the complexity of the disease. The day also covered sessions on the biology of Alzheimer’s disease, updates on drug and therapy development, and new strategies for prevention.

Video of Summit Day 2 explores innovations in disease monitoring, assessment, and care; engaging and empowering people in research, and enabling partnerships for collaboration.

Visit the Summit website to learn more about the diverse group of speakers and view the Summit agenda

San Diego County Officials Launch Attack on Alzheimer's

With Alzheimer's disease rapidly becoming one of the most critical public health issues facing us today, The Alzheimer’s Association is proud to announce that San Diego County Officials are fighting back with the the Alzheimer’s Project Initiative, that launched on May 6, 2014.

The initiative, put forth by San Diego County Board of Supervisors Chairwoman Dianne Jacob and San Diego County Supervisor Dave Roberts, will bring together health care experts, leaders of the Alzheimer’s Association, world-renown researchers and others to craft a strategy aimed at improving local care and developing a cure.

During the coming months, all those involved with the Alzheimer’s Project will collaborate and explore ways to boost research funding and public awareness as well as make recommendations to improve services for those with dementia and their caregivers. Project participants are expected to bring their recommendations to the Board of Supervisors before the end of this year.

CLICK HERE to read more about the Alzheimer's Project.
CLICK HERE to read the official press release.

Movement Disorders in the News:

Researchers at the San Diego Supercomputer Center (SDSC) at the University of California, San Diego, have shown for the first time why protein mutations lead to the familial form of Parkinson’s disease

The study, available online in prepublication in ACS Chemical Neuroscience and partially funded by the National Institutes of Health, focuses specifically onalpha-synuclein (αsyn), a protein whose function in healthy tissue is unknown but which represents the major structural component of Lewy bodies – protein clumps found in the brains of individuals with Parkinson’s disease and other neurological disorders.

To read the article, click here

New Resources:

Early-onset Alzheimer's disease, occurring in people age 30 to 60, is rare but complicated. People living with early-onset Alzheimer’s (like Julianne Moore’s character in the movie “Still Alice”) may face particular challenges in dealing with work, raising children, and finding the right support groups.
A new online resource list from the National Institute on Aging’s Alzheimer’s Disease Education and Referral Center may assist younger people with Alzheimer’s, their families, and caregivers to find information and help. Topics include:

Living with early-onset Alzheimer’s
Legal and financial planning
Caregiving
Clinical trials and studies

All of the resources on this list are free and accessible online.
Visit the ADEAR Center website for other resources like free publications, caregiving resources, and more information about Alzheimer’s.

The ADEAR Center is now on Twitter!

Follow @Alzheimers NIH for daily tweets linking you to:

News about Alzheimer's and related research
Alzheimer's facts and tips
caregiving resources
information about Alzheimer's clinical trials

@Alzheimer's NIH is a great resource for researchers, professionals, and caregivers. Follow us today and start sharing ADEAR Center information with your own followers.

For more Alzheimer’s disease information and resources, visit www.nia.nih.gov/Alzheimers.

Alzheimers.gov launched

In conjunction with the release of the National Alzheimer’s Plan, the U.S. Department of Health and Human Resources (HHS) launched a critical new resource for families and individuals facing Alzheimer’s. A new website, alzheimers.gov, and an accompanying ad campaign were developed by HHS in collaboration with the Alzheimer’s Association to help raise awareness and provide support to those living with the disease. The ad campaign will begin later this summer.